Some studies indicated that the expression of CTHRC1 is also modulated by epigenetic changes, such as promoter demethylation, which can be reversed by treatment with demethylating agents, suggesting that CTHRC1’s upregulation is linked to both tumor progression and metastasis (24). This evidence concerns the gene CTHRC1 and neoplasm.